Strong Membership and Revenue Growth
Q4 health plan membership of 236,300 (≈25% YoY growth). Full-year membership up 25% YoY. Q4 revenue of $1.0B (44% YoY growth) and full-year revenue of $3.9B (46% YoY growth).
Profitability and Margin Expansion
Full-year adjusted EBITDA of $110M vs roughly breakeven in 2024 (adjusted EBITDA margin 2.8%), representing ~270 basis points of margin expansion year-over-year. Q4 adjusted EBITDA of $11M, outperforming guidance (vs. guidance of negative $9M to negative $1M).
Improved Medical Benefit Ratio and Adjusted Gross Profit
Full-year adjusted gross profit $495M with a consolidated MBR of 87.5%, an improvement of 130 basis points YoY. Q4 adjusted gross profit $125M and adjusted MBR of 87.7%.
Operational Leverage and SG&A Efficiency
Full-year adjusted SG&A $385M (28% increase YoY in absolute dollars) but SG&A as a percent of revenue declined from 11.1% to 9.7% (≈140 basis points improvement), reflecting operating leverage as membership scaled.
Cash Flow and Balance Sheet Strength
Generated positive free cash flow in 2025 and ended the year with $604M in cash and investments. Closed a $200M revolving credit facility (not expected to be drawn), supporting capital structure maturation.
Successful AEP / Early 2026 Momentum
January 2026 membership grew to 275,300 (31% YoY). Broad growth across markets: 23% growth in California and >80% growth in ex-California counties. Nearly 20% improvement in AEP voluntary disenrollment and ~80% of gross sales sourced from plan switchers.
Replicable Quality Across Markets (Star Ratings)
100% of members and plans rated 4 stars or above. Notable plan ratings include a 5-star plan in North Carolina (3rd consecutive year), two 5-star plans in Nevada, a 4.5-star plan in Texas and a 4-star plan in Arizona, demonstrating quality portability outside California.
Technology & Care Model Advantages
Continued emphasis on AIVA/AVA data platform and Care Anywhere clinical model to improve visibility, cost control and scalability; targeted midyear deployments of AI use cases and workflow improvements expected to accelerate efficiency and scale.
Updated 2026 Guidance
2026 guidance: membership 292k–298k; revenue $5.14B–$5.19B (midpoint ≈31% YoY growth); adjusted gross profit $615M–$650M (midpoint MBR ≈87.7%); adjusted EBITDA $133M–$163M. Membership guidance midpoint raised by 2,000 since prior 8-K.
Recognition and Brand Momentum
Named to Fortune Magazine's World's Most Admired Companies list for the first time, reflecting external validation of the company's senior care focus.